IP Verse

Transgenic Mouse Which Produces Hybrid Antibodies Containing Human Variable Regions And Mouse Constant Regions - EP3626819

PATENT ANALYSIS

Patent Details

Grant Date
Mar 31, 2021
Company
REGENERON PHARMACEUTICALS, INC.
Oppositions

KYMAB LIMITED

More patents of Regeneron Pharmaceuticals, Inc.

EP4011915

EP2967015

EP3384049

Want to monitor this patent?

Feel free to send us a message here and we will get back to you